Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 4, 2009, Pages 385.e1-385.e5

  Habli, Mounira ^a   Eftekhari, Nahid ^a   Wiebracht, Emily ^a   Bombrys, Annette ^a   Khabbaz, Maram ^a   How, Helen ^a   Sibai, Baha ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

cardiovascular; HELLP; long term; preeclampsia; subsequent pregnancy

Indexed keywords

LIVER ENZYME;

ADULT; ANXIETY DISORDER; ARTICLE; ASTHMA; BLINDNESS; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HELLP SYNDROME; HEMODIALYSIS; HEMOLYSIS; HUMAN; HYPERTENSION; HYPOTHYROIDISM; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MARRIAGE; MATERNAL AGE; MEDICAL RECORD; MORBIDITY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; THROMBOCYTE COUNT;

EID: 70349312358     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.06.033     Document Type: Article

References (23)

1. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes and low platelet count. Obstet Gynecol 103 (2004) 981-991
2. Sullivan C.A., Magann E.F., Perry K.G., Roberts E.W., Blake P.G., and Martin J.N. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 171 (1994) 940-943
3. Sibai B.M., Ramadan M.K., Chari R.S., and Friedman S.A. Pregnancies complicated by HELLP syndrome: subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 172 (1995) 125-129
4. Van Pampus M.G., Wolf H Mayruhu G., Treffers P.E., and Bleker O.P. Long term follow-up in patients with a history of HELLP syndrome. Hypertens Pregnancy 20 (2001) 15-23
5. Rizk N.W., Kalassian K.G., Gilligan T., et al. Obstetric complications in pulmonary and critical care medicine. Chest 110 (1996) 791-809
6. Karnad D.R., Lapsia V., Krishman A., et al. Prognostic factors in obstetric patients admitted to an Indian intensive care unit. Crit Care Med 32 (2004) 1294-1299
7. Hupuczi P., Sziller I., Hruby E., Rigó B., Szabó G., and Papp Z. The rate of maternal complications in 107 pregnancies complicated with HELLP syndrome. Orv Hetil 147 (2006) 1377-1385
8. McDonald S.D., Malinowski A., Zhou Q., Yusuf S., and Devereaux P.J. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 156 (2008) 918-930
9. Chames M.C., Haddad B., Barton J.R., Livingston J.C., and Sibai B.M. Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol 188 (2003) 1504-1507
10. Sibai B.M., Ramadan M.K., Usta I., Salama M., Mercer B.M., and Friedman S.A. Maternal morbidity and mortality in 442 pregnancies with HELLP syndrome. Am J Obstet Gynecol 169 (1993) 1000-1006
11. Gaugler-Senden I.P., Berends A.L., de Groot C.J., and Steegers E.A. Severe, very early onset preeclampsia: subsequent pregnancies and future parental cardiovascular health. Eur J Obstet Gynecol Reprod Biol 140 (2008) 171-177
12. Zeek P.M., and Assali N.S. Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am J Clin Pathol 20 (1950) 1099-1109
13. Brosens J.J., Pijnenborg R., and Brosens I.A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187 (2002) 1416-1423
14. Said J., and Dekker G. Pre-eclampsia and thrombophilia. Best Pract Res Clin Obstet Gynaecol 17 (2003) 441-458
15. Ray J.G. Dysmetabolic syndrome, placenta-mediated disease and future risk of cardiovascular disease. Fetal Matern Med Rev 15 (2004) 1-16
16. O'Brien T.E., Ray J.G., and Chan W.S. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14 (2003) 368-374
17. Innes K.E., Wimsatt J.H., and McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol 97 (2001) 905-910
18. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 5-15
19. Chambers J.C., Fusi L., Malik I.S., et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA 285 (2001) 1607-1612
20. National Center for Health Statistics, Health, United States, 2007, with chartbook on trends in the health of Americans (2007), US Government Printing Office, Hyattsville, MD Table 70
21. Van Pampus M.G., and Wolf H.S. PTSD following preeclampsia and HELLP syndrome. J Psychosom Obstet Gynecol 25 (2004) 183-187
22. Hirashima C., Ohkuchi A., Matsubara S., et al. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. Hypertens Res 31 (2008) 1541-1548
23. Tripathi R., Rath G., Jain A., and Salhan S. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia. Ann Anat 190 (2008) 477-489